Literature DB >> 12213794

Screening for left ventricular dysfunction: a step too far?

T A McDonagh1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12213794      PMCID: PMC1876273          DOI: 10.1136/heart.88.suppl_2.ii12

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  23 in total

1.  Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction.

Authors:  R S Vasan; M G Larson; E J Benjamin; J C Evans; D Levy
Journal:  N Engl J Med       Date:  1997-05-08       Impact factor: 91.245

2.  Value of ECGs in identifying heart failure due to left ventricular systolic dysfunction.

Authors:  A P Davie; M P Love; J J McMurray
Journal:  BMJ       Date:  1996-08-03

3.  Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: cross sectional survey.

Authors:  S Morgan; H Smith; I Simpson; G S Liddiard; H Raphael; R M Pickering; D Mant
Journal:  BMJ       Date:  1999-02-06

4.  Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population.

Authors:  T A McDonagh; A D Cunningham; C E Morrison; J J McMurray; I Ford; J J Morton; H J Dargie
Journal:  Heart       Date:  2001-07       Impact factor: 5.994

Review 5.  Economics of chronic heart failure.

Authors:  C Berry; D R Murdoch; J J McMurray
Journal:  Eur J Heart Fail       Date:  2001-06       Impact factor: 15.534

6.  Relationship between left ventricular geometry and brain natriuretic peptide levels in elderly subjects.

Authors:  H Sayama; Y Nakamura; N Saito; M Kinoshita; M Suda
Journal:  Gerontology       Date:  2000 Mar-Apr       Impact factor: 5.140

7.  Biochemical detection of left-ventricular systolic dysfunction.

Authors:  T A McDonagh; S D Robb; D R Murdoch; J J Morton; I Ford; C E Morrison; H Tunstall-Pedoe; J J McMurray; H J Dargie
Journal:  Lancet       Date:  1998-01-03       Impact factor: 79.321

Review 8.  Measurement and significance of circulating natriuretic peptides in cardiovascular disease.

Authors:  G A Sagnella
Journal:  Clin Sci (Lond)       Date:  1998-11       Impact factor: 6.124

9.  Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction.

Authors:  J G Motwani; H McAlpine; N Kennedy; A D Struthers
Journal:  Lancet       Date:  1993-05-01       Impact factor: 79.321

10.  Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study.

Authors:  A L Stewart; S Greenfield; R D Hays; K Wells; W H Rogers; S D Berry; E A McGlynn; J E Ware
Journal:  JAMA       Date:  1989-08-18       Impact factor: 56.272

View more
  1 in total

Review 1.  Natriuretic peptide-guided treatment for the prevention of cardiovascular events in patients without heart failure.

Authors:  Claire Sweeney; Fiona Ryan; Mark Ledwidge; Cristin Ryan; Ken McDonald; Chris Watson; Rebabonye B Pharithi; Joe Gallagher
Journal:  Cochrane Database Syst Rev       Date:  2019-10-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.